Literature DB >> 9440186

Persistent hyperplastic primary vitreous: diagnosis, treatment and results.

Z F Pollard1.   

Abstract

While the great majority of patients with persistent hyperplastic primary vitreous never obtain useful vision, it is encouraging that 18.07% of all the patients in this series did achieve 20/200 vision or better (Table V). In the whole group, 12 of 83, or 14.45%, obtained 20/70 vision or better with treatment. All of these successful results were in eyes with the purely anterior PHPV only. In fact, when looking at the results of the anterior PHPV cases alone, 15 of 21 achieved 20/200 or better, which was 71.4% of the patients with anterior presentation only. In this anterior group, 12 of 21 (57.1%) attained 20/70 vision or better with treatment. The goals of treatment with PHPV should always be kept in mind when confronted with an infant who has this entity. First, an effort should be made to save the eye from glaucoma or phthisis, which are the most devastating results of untreated PHPV. A lensectomy will usually prevent the secondary glaucoma, which results from the lens-iris diaphragm being pushed forward to cause a secondary angle-closure glaucoma. A secondary glaucoma can also be produced from recurrent hyphema, which scars the outflow passageways in the angle. By removing the PHPV membrane and reducing the tractional forces applied to the ciliary body by the membrane, one can lessen the possibility of phthisis. Surgery reduces the centripetal, as well as axial, forces generated by the membrane. The second goal is to produce a black pupil for cosmetic reasons, and the third goal of obtaining useful vision is reasonable to expect if the entity presents with only anterior involvement. Bilaterality, while rare in this series (2:83 cases, or 2.4%), was a very poor prognosis for vision, since both patients had only light perception to hand motion vision in both eyes. With the exception of the eye problems, these two children were otherwise normal in their physical and mental development. No measurable stereopsis or binocularity has been achieved in any of these patients. This was primarily because 100% of the patients had strabismus and secondarily to the fact that in the patients with good surgical results, aggressive and prolonged patching may have precluded the development of binocular vision. Two patients have uncontrolled glaucoma with only light perception vision. Both of these patients are comfortable and pain-free. Two patients have, in time, developed phthisis and wear a cosmetic shell. No cases have required enucleation in this series. (The pathological specimen from Figs 1 and 2 represents an enucleated eye during my residency.) Two patients developed an extensive cyclitic membrane after surgery, which completely occluded the pupillary space. Both patients had originally undergone extensive membrane removal of their PHPV with the production of a nice clear pupillary space. The first patient developed the cyclitic membrane only 3 weeks after the original surgery. A second surgery has been successful in clearing the pupillary opening, but the patient has only hand motion vision at 1 foot due to amblyopia. The second patient had been fitted with a gas-permeable hard contact lens after original surgery for an anterior PHPV. An extensive cyclitic membrane developed 4 months later and required a secondary procedure to clear the pupillary space. The patient's pupillary space has remained open after this second procedure, and the patient is currently wearing a contact lens and undergoing amblyopia therapy. The most important factor in the prognosis of patients with persistent hyperplastic primary vitreous is the extent of the membrane. Families should be told that if their child has only an anterior presentation, then surgical and amblyopia therapies offer a good chance for useful vision. Patients with a combination of anterior and posterior PHPV, or patients with only a posterior PHPV, should be advised that there is a reasonable opportunity to save the eye from glaucoma and phthisis, but that useful vision is usually not

Entities:  

Mesh:

Year:  1997        PMID: 9440186      PMCID: PMC1298374     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  92 in total

1.  Persistent hyperplastic primary vitreous; special reference to preretinal glial tissue as a pathological characteristic and to the development of the primary vitreous.

Authors:  W A MANSCHOT
Journal:  AMA Arch Ophthalmol       Date:  1958-02

2.  Persistent hyperplastic primary vitreous.

Authors:  A B REESE
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1955 May-Jun

3.  Persistent hyperplastic primary vitreous.

Authors:  A B REESE
Journal:  Am J Ophthalmol       Date:  1955-09       Impact factor: 5.258

4.  Growth of the internal and external eye in term and preterm infants.

Authors:  S J Isenberg; D Neumann; P Y Cheong; Y L Ling; L C McCall; A J Ziffer
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

5.  [Value of ultrasonography in persistent hyperplastic primary vitreous body. Apropos of 4 cases].

Authors:  F Bencherifa; A Boulanouar; M el Bakkali; Y Benzekri; N Lamdouar-Bellakhdar
Journal:  J Fr Ophtalmol       Date:  1993       Impact factor: 0.818

6.  Persistent hyperplastic primary vitreous.

Authors:  H Verbraeken
Journal:  Bull Soc Belge Ophtalmol       Date:  1993

7.  [The importance of the early diagnosis of primary persistent hyperplastic vitreous].

Authors:  L Sireteanu; C Tudor
Journal:  Oftalmologia       Date:  1994 Oct-Dec

8.  Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome).

Authors:  M F Goldberg; P H Custis
Journal:  Ophthalmology       Date:  1993-11       Impact factor: 12.079

9.  Persistent hyperplastic primary vitreous in association with Aicardi syndrome.

Authors:  D J Weissgold; A M Maguire; N S Kalin; R W Hertle
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1995 Jan-Feb       Impact factor: 1.402

10.  Glaucoma following childhood cataract surgery.

Authors:  M D Mills; R M Robb
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1994 Nov-Dec       Impact factor: 1.402

View more
  28 in total

1.  Bilateral Persistent Hyperplastic Primary Vitreous: A Case Report and Review of the Literature.

Authors:  Hamza Maqsood; Shifa Younus; Maham Fatima; Muhammad Saim; Shaheryar Qazi
Journal:  Cureus       Date:  2021-02-03

2.  Outcomes in persistent hyperplastic primary vitreous.

Authors:  A Hunt; N Rowe; A Lam; F Martin
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Ciliary body medulloepithelioma with neoplastic cyclitic membrane imaging with fluorescein angiography and ultrasound biomicroscopy.

Authors:  Priya Sharma; Carol L Shields; Kiran Turaka; Ralph C Eagle; Jerry A Shields
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-20       Impact factor: 3.117

4.  Bilateral Persistent Hyperplastic Primary Vitreous - A Rare Case Report.

Authors:  Rashmi Kumari; Bhawesh Chandra Saha
Journal:  J Clin Diagn Res       Date:  2017-09-01

5.  Outcomes of small gauge pars plicata vitrectomy for patients with persistent fetal vasculature: a report of 105 cases.

Authors:  Jing-Hua Liu; Hai Lu; Song-Feng Li; Yong-Hong Jiao; Nan Lin; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

6.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

7.  Unoperated eyes with persistent fetal vasculature.

Authors:  Nishi Gulati; Ralph C Eagle; William Tasman
Journal:  Trans Am Ophthalmol Soc       Date:  2003

8.  Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.

Authors:  Amy C Martin; J Derek Thornton; Jiewiu Liu; XiaoFei Wang; Jian Zuo; Monica M Jablonski; Edward Chaum; Frederique Zindy; Stephen X Skapek
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

9.  p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.

Authors:  Nida S Iqbal; Caitlin C Devitt; Caroline Y Sung; Stephen X Skapek
Journal:  Exp Eye Res       Date:  2016-01-08       Impact factor: 3.467

10.  A nonautonomous role for retinal frizzled-5 in regulating hyaloid vitreous vasculature development.

Authors:  Jianmin Zhang; Sabine Fuhrmann; Monica L Vetter
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.